Therapy of small cell lung cancer with emphasis on oral topotecan

被引：12

作者：

Pirker, Robert ^{[1
]}

Berzinec, Peter ^{[2
]}

Brincat, Stephen ^{[3
]}

Kasan, Peter ^{[4
]}

Ostoros, Gyula ^{[5
]}

Pesek, Milos ^{[6
]}

Plate, Signe ^{[7
]}

Purkalne, Gunta ^{[8
]}

Rooneem, Regina ^{[9
]}

Skrickova, Jana ^{[10
]}

Stanculeanu, Dana ^{[11
]}

Timcheva, Constanta ^{[12
]}

Tzekova, Valentina ^{[13
]}

Zakotnik, Branko ^{[14
]}

Zielinski, Christoph C. ^{[1
]}

Zwitter, Matjaz ^{[15
]}

机构：

[1] Med Univ Vienna, Dept Med 1, A-1090 Vienna, Austria

[2] Specialised Hosp St Zoerardus Zobor, Dept Oncol, Nitra, Slovakia

[3] Sir Paul Boffa Hosp, Floriana, Malta

[4] Univ Hosp Bratislava, Dept Oncol, Bratislava, Slovakia

[5] Natl Koranyi Inst TB & Pulmonol, Budapest, Hungary

[6] Charles Univ Prague, Fac Med, Plzen, Czech Republic

[7] Riga Easten Univ Hosp, Riga, Latvia

[8] Paul Stradins Clin Univ Hosp Riga, Radiat & Chemotherapy Ctr, Riga, Latvia

[9] N Estonia Reg Hosp, Ctr Canc, Dept Chemotherapy, Tallinn, Estonia

[10] Univ Hosp, Dept Resp Dis & TB, Brno, Czech Republic

[11] Inst Oncol, Bucharest, Romania

[12] Specialized Hosp Active Treatment Oncol, Sofia, Bulgaria

[13] ISUL, Univ Hosp Queen Joanna, Clin Chemotherapy, Sofia, Bulgaria

[14] Inst Oncol Ljubljana, Div Med Oncol, Ljubljana, Slovenia

[15] Inst Oncol Ljubljana, Dept Radiat Oncol, Ljubljana, Slovenia

来源：

LUNG CANCER | 2010年 / 70卷 / 01期

关键词：

Chemotherapy; New drugs; Thoracic radiotherapy; Brain irradiation; Second-line therapy; Topotecan; PROPHYLACTIC CRANIAL IRRADIATION; PREVIOUSLY UNTREATED PATIENTS; CISPLATIN PLUS ETOPOSIDE; LONG-TERM SURVIVAL; PHASE-III TRIAL; PROGNOSTIC-FACTORS; THORACIC RADIOTHERAPY; 2ND-LINE TREATMENT; CHEMOTHERAPY; AMRUBICIN;

D O I：

10.1016/j.lungcan.2010.05.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Systemic chemotherapy plays the major role in the management of patients with small cell lung cancer. Cisplatin plus etoposide is the most widely used regimen and is considered as standard in patients with limited disease. Cisplatin plus irinotecan improved survival compared to cisplatin plus etoposide in a Japanese trial but failed to do so in two trials in Caucasians. Cisplatin plus topotecan had similar efficacy compared to cisplatin plus etoposide in patients with extensive disease. In the second-line setting, topotecan showed similar efficacy but better tolerability compared to cyclophosphamide, doxorubin plus vincristine. Oral topotecan was as efficacious as its intravenous formulation and was shown to improve survival compared to best supportive care alone in patients previously treated with chemotherapy. Thus topotecan is considered as the standard second-line chemotherapy in patients with small cell lung cancer. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：7 / 13

页数：7

共 50 条

[1] Topotecan in small cell lung cancer
Campling, B
CANCER BIOLOGY & THERAPY, 2004, 3 (01) : 94 - 95
[2] Small cell lung cancer
Steins, M. B.
Henkenberens, C.
Bremer, M.
Thomas, M.
ONKOLOGE, 2016, 22 (10): : 799 - 810
[3] Topotecan for the treatment of small-cell lung cancer
Nicum, Shibani J.
O'Brien, Mary E. R.
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 795 - 801
[4] Multidisciplinary Management of Small Cell Lung Cancer
Goldberg, Sarah B.
Willers, Henning
Heist, Rebecca S.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (02) : 329 - +
[5] Therapeutic procedure in small cell lung cancer
Kallianos, Anastasios
Rapti, Aggeliki
Zarogoulidis, Paul
Tsakiridis, Kosmas
Mpakas, Andreas
Katsikogiannis, Nikolaos
Kougioumtzi, Ioanna
Li, Qiang
Huang, Haidong
Zaric, Bojan
Perin, Branislav
Courcoutsakis, Nikolaos
Zarogoulidis, Konstantinos
JOURNAL OF THORACIC DISEASE, 2013, 5 : S420 - S424
[6] Optimal Radiation Therapy for Small Cell Lung Cancer
Gensheimer, Michael F.
Loo, Billy W., Jr.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (04)
[7] The Role of Radiation Therapy in Small Cell Lung Cancer
Videtic, Gregory M. M.
CURRENT ONCOLOGY REPORTS, 2013, 15 (04) : 405 - 410
[8] Treatment advances in small cell lung cancer (SCLC)
Waqar, Saiama N.
Morgensztern, Daniel
PHARMACOLOGY & THERAPEUTICS, 2017, 180 : 16 - 23
[9] Update 2021: Management of Small Cell Lung Cancer
Tariq, Sara
Kim, So Yeon
Novaes, Jose Monteiro de Oliveira
Cheng, Haiying
LUNG, 2021, 199 (06) : 579 - 587
[10] Multimodality approaches in the treatment of small cell lung cancer
Deppermann, K. -M.
Niederle, N.
Fleckenstein, J.
Passlick, P.
ONKOLOGE, 2013, 19 (11): : 930 - +

← 1 2 3 4 5 →